The TMC435 SVR data in #msg-67609174 are impressive, IMO. The only thing I question in the dataset from the PILLAR study is the relapse of some patients more than six months after the end of treatment, but this is presumably a fluke rather than an indictment of TMC435.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.